Latest news
Actinogen Medical Presents Xanamem Alzheimer's Data at Bioshares Biotech Summit - KalkineKalkine · Thu, 06 Aug 2026 02:54:16 GMTActinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 00:10:39 GMTActinogen Medical’s Xanamem Alzheimer’s Treatment: 2026 Trial Update - Discovery AlertDiscovery Alert · Wed, 05 Aug 2026 15:35:10 GMTActinogen to Host Alzheimer’s Treatment Forum as Xanamem Program Advances - TipRanksTipRanks · Wed, 05 Aug 2026 03:05:21 GMTActinogen Medical targets Alzheimer’s treatment gap in projected $20BN market - Proactive financial newsProactive financial news · Wed, 05 Aug 2026 01:50:00 GMTActinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI - Proactive financial newsProactive financial news · Sat, 01 Aug 2026 00:00:33 GMTActinogen Medical (ASX:ACW) Gains Momentum as Alzheimer’s Trial Progress and Regulatory Milestones Lift Investor Confidence - KalkineKalkine · Thu, 30 Jul 2026 07:00:00 GMTActinogen Medical keeps pivotal Alzheimer’s trial on track for November readout - Proactive financial newsProactive financial news · Thu, 30 Jul 2026 01:07:56 GMT